IPSC Laboratory for CNS Disease Modeling
11 – 20 of 51
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2020
-
Mark
NF-E2-related factor 2 activation boosts antioxidant defenses and ameliorates inflammatory and amyloid properties in human Presenilin-1 mutated Alzheimer's disease astrocytes
(
- Contribution to journal › Article
-
Mark
Unique signatures of stress-induced senescent human astrocytes
(
- Contribution to journal › Article
-
Mark
Generation of an induced pluripotent stem cell line (CSC-32) from a patient with Parkinson's disease carrying a heterozygous variation p.A53T in the SNCA gene
(
- Contribution to journal › Article
-
Mark
Oligodendroglial (dys)function in alpha-synucleinopathies
2020) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
-
Mark
Human iPSC-Derived Hippocampal Spheroids : An Innovative Tool for Stratifying Alzheimer Disease Patient-Specific Cellular Phenotypes and Developing Therapies
(
- Contribution to journal › Article
-
Mark
Demonstration of brain region-specific neuronal vulnerability in human iPSC-based model of familial Parkinson's disease
(
- Contribution to journal › Article
-
Mark
Stem cell-based models to study cellular alterations in Parkinson’s Disease
2020) In Lund University, Faculty of Medicine Doctoral Dissertation Series(
- Thesis › Doctoral thesis (compilation)
- 2019
-
Mark
Generation of an induced pluripotent stem cell line (CSC-46) from a patient with Parkinson's disease carrying a novel p.R301C mutation in the GBA gene
(
- Contribution to journal › Article
-
Mark
PARK2 mutation causes metabolic disturbances and impaired survival of human iPSC-derived neurons
(
- Contribution to journal › Article
-
Mark
FGF family members differentially regulate maturation and proliferation of stem cell-derived astrocytes
(
- Contribution to journal › Article